Portoencephalopathy Treatment Pharmaceutical Raw Powders Glipizide CAS 29094-61-9
| CAS No.: | 29094-61-9 | Other Names: | Glipizide 29094-61-9 | MF: | C21H33N5O4S |
| EINECS No.: | 249-427-6 | Place of Origin: | China (Mainland) | Type: | Blood System Agents |
| Grade Standard: | Medicine Grade, Tech Grade | Usage: | Animal Pharmaceuticals | Brand Name: | Lonwin |
| Model Number: | HUISUN-A | Purity: | 99% Min | Product Name: | Glipizide |
| Appearance:: | White Crystal Powder | Test method:: | HPLC | Service Attitude:: | ^_^ |
| MW:: | 451.5828 | Melting point:: | 208-209°C | Density:: | 1.29g/cm3 |
| Water solubility:: | methanol: 1.9 mg/mL | Refractive index:: | 1.597 | Assay: | 99.0~101.0% |
| Packaging Details: |
0.5kgs/Al-foil bag 1.0kgs/Al-foil bag 2.0kgs/Al-foil bag 5.0 kgs/Al-foil bag 25.0 kgs/drum or upon customers' request. |
| Delivery Detail: | Shipped in 3 days after payment |
Glipizide
Introduction:
Glipizide is an oral rapid- and short-acting anti-diabetic drug from the sulfonylurea class. It is classified as a second generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas.
Specification:
| Tests | Specifications | Results |
| Appearance | White or almost white crystalline powder | White crystalline powder |
| Identification | IR: The IR absorption spectrum of sample corresponds to that of reference one | Complies |
| Loss on drying | Not more than 0.5% | 0.1% |
| Residue on ignition | Not more than 0.2% | 0.03% |
|
Related substances Impurity A Impurity X3 Unspecified impurity Total impurities |
Not more than 0.3% Not more than 0.15% Not more than 0.10% Not more than 0.5% |
0.10% 0.08% 0.04% 0.26% |
| Impurity B | Not more than 0.01% | N.D |
| Assay |
98.0%~102.0% ( Calculated on dried basis) |
99.4% |
| Conclusion | Complies with EP7.0 | |